All Stories

  1. Morphometric and structural dynamic parameters of hepatitis viruses: implications for therapeutic and vaccine failure
  2. Relationship Between Virtual Pharmacology Lecture, Attendance and Performance: Personal Experience With Veterinary Students of the University of BUEA, Southwest Cameroon
  3. Structure-activity relationship of pharmacophores and toxicophores: the need for clinical strategy
  4. Prediction of new likely emergent amino acid point mutations from USA, UK, Italy, France, Brazil, and India SARS-CoV-2 variants: a possible source for more reliable cocktail coronavirus vaccine
  5. Ameliorative effects of piroxicam on perchloric acid-induced thyroid gland hormones disruption in male rats
  6. Mutation of amino acids in SARS-CoV-2 may be responsible for CoV-2 vaccine long term inefficiency
  7. Acute toxicity study, haematological, biochemical and histopathological effects of Brassica oleracea var. capitata, Allium porrum and Cucurbita maxima in Rattus norvegicus
  8. Protection of SARS-CoV-2 trial vaccines in human is a function of the viral genomes
  9. Correction to: Comparative local anaesthetic activity of lignocaine, lignocaine-adrenaline and water extracts of Annona muricata during castration in dogs
  10. Biomedical Applications of Polyurethane Hydrogels, Polyurethane Aerogels, and Polyurethane-graphene Nanocomposite Materials
  11. Comparative local anaesthetic activity of lignocaine, lignocaine-adrenaline and water extracts of Annona muricata during castration in dogs
  12. Application of modified Michaelis – Menten equations for determination of enzyme inducing and inhibiting drugs
  13. Genetic diversity of canine parvovirus variants circulating in Nigeria
  14. Pro-fertility effects of hydroalcoholic extract of Psidium guajava leaves in female Wistar rats
  15. Modified formulas for calculation of encephalization: quotient in dogs
  16. Tumorigenic Potential of Dimethyl Sulfoxide, Anthracene in Fish and Anthracene in Dimethyl Sulfoxide in Rattus Norvegicus
  17. Comparative therapeutic index, lethal time and safety margin of various toxicants and snake antivenoms using newly derived and old formulas
  18. Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development
  19. Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
  20. Effects of Propofol Anaesthesia Pre-Medicated with Xylazine on Serum Biochemical Profiles and Sleep Pattern in Red Sokoto Goats
  21. Epizootiology of Infectious Diseases of Dog in Some States in Nigeria (2015–2018)
  22. Therapeutic effects of Byrsocarpus coccineus root bark extract on bacterially and chemically induced diarrhea in the Wistar albino rat (Rattus norvegicus domestica)
  23. Chemistry and Effects of Brainstem Acting Drugs
  24. Chirality of Central Nervous System (CNS) Acting Drugs: A Formidable Therapeutic Hurdle Against CNS Diseases
  25. Mathematical determination of some oncological parameters and their therapeutic implications in dogs
  26. Comparative Haematological and Biochemical Effects of Cocktail Vaccine (DHLPPi) and Abrus precatorius Seed Aqueous Extract on Canine Parvoviral Vaccinated and Unvaccinated Nigerian Local Dogs
  27. Determination of median effective dose (ED50) of scorpion antivenom against scorpion envenomation using a newly developed formula
  28. The use of body surface area for determination of age, body weight, urine creatinine, plasma creatinine, serum creatinine, urine volume, and creatinine clearance: the reliable canonical method of assessing renotoxicity in animals
  29. Calculation of effective dose fifty (ED50) of antivenom for American pit viper envenomation
  30. Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
  31. Phytochemical screening, proximate analysis, median lethal dose (LD50), hematological and biochemical effects of various extracts of Abrus precatorius seeds in Mus musculus
  32. In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants
  33. Functional Chemical Groups that May Likely Become a Source for the Synthesis of Novel Central Nervous System (CNS) Acting Drugs
  34. Piroxicam: Source for Synthesis of Central Nervous System (CNS) Acting Drugs
  35. Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
  36. Effects of piroxicam on tissue distribution of sulfadimidine in West African Dwarf male and female goats
  37. Toxicity studies of drugs and chemicals in animals: an overview
  38. The Pattern of Sickle Cell Disease in Sickle Cell Patients from Northwestern Nigeria
  39. The new algorithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) of Micrarus fulvius venom and anti-venom in mice
  40. Physicochemical and structure-activity properties of piroxicam—a mini review
  41. The Paradox of Human Equivalent Dose Formula: A Canonical Case Study of Abrus Precatorius Aqueous Leaf Extract in Monogastric Animals
  42. Toxico-Neurological Effects of Piroxicam in Monogastric Animals
  43. Comparative Pharmacokinetics of Intramuscular Sulphadimidine in Non-starved and Starved Grower Turkeys (Meleagris gallopavo)
  44. A review on urolithiasis in dogs and cats
  45. A modified arithmetical method of Reed and Muench for determination of a relatively ideal median lethal dose (LD50)
  46. Haematonic and plasma expander effects of aqueous leaf extract of Abrus precatorius in Mus musculus
  47. A Photo Album of Some Medicinal Plants of the Nigerian Middle Belt
  48. Tropical Plants with Antihypertensive, Antiasthmatic, and Antidiabetic Value